Progress of antibody-based inhibitors of the HGF–cMET axis in cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry
Link
http://www.nature.com/articles/emm201717.pdf
Reference68 articles.
1. Tempest PR, Stratton MR, Cooper CS . Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br J Cancer 1988; 58: 3–7.
2. Donate LE, Srinivasan N, Sowdhamini R, Gherardi E, Blundell TL, Aparicio S . Molecular evolution and domain structure of plasminogen‐related growth factors (HGF/SF and HGF1/MSP). Protein Sci 1994; 3: 2378–2394.
3. Kirchhofer D, Yao X, Peek M, Eigenbrot C, Lipari MT, Billeci KL et al. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. J Biol Chem 2004; 279: 39915–39924.
4. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF . Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915–925.
5. Blumenschein GR, Mills GB, Gonzalez-Angulo AM . Targeting the hepatocyte growth factor-cMET axis in cancer therapy. J Clin Oncol 2012; 30: 3287–3296.
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MST1R-targeted therapy in the battle against gallbladder cancer;Cell & Bioscience;2024-08-29
2. Differential Immune Checkpoint Protein Expression in HNSCC: The Role of HGF/MET Signaling;International Journal of Molecular Sciences;2024-07-04
3. Tumor biomarkers for diagnosis, prognosis and targeted therapy;Signal Transduction and Targeted Therapy;2024-05-20
4. Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies;Drug Delivery and Translational Research;2024-04-10
5. Encapsulating Epigallocatechin-3-Gallate (EGCG) in Chitosan Nanoparticles Influenced Multiple Genes Controlling Oncostatic Signaling Pathways in HepG2 Cells;Revista Brasileira de Farmacognosia;2024-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3